Skip to main content

Postdoc Portrait: Pooja Mittal Investigates Molecular Biomarkers in Colorectal Cancer

This postdoctoral researcher explores biomarkers and the tumor microenvironment. She hopes to develop therapeutic strategies to combat colorectal cancer.

Brought to you byThe Scientist
| 2 min read
Headshot of postdoctoral researcher Pooja Mittal.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Pooja Mittal is a postdoctoral researcher at the University of Southern California Keck School of Medicine. In this Postdoc Portrait, she discusses how her work focuses on finding new and effective treatment strategies for colorectal cancer.

Colorectal Cancer Therapies and Tumor Microenvironment

Q | What drew you to studying colorectal cancer?

Colorectal cancer is one of the most common causes of cancer-related mortality worldwide and thus it is a very important research field. The major target that drew me towards this field was myeloid cell leukemia-1 (MCL-1) which is a protein that helps the cancer cells to avoid cell death.

Q | What scientific problem are you trying to solve?

I am currently working to identify and analyze different biomarkers in colorectal cancer. Another domain of my research includes identifying new treatments against these biomarkers. The biomarkers and associated therapies will subsequently result in better diagnosis, treatment and prognosis of colorectal cancer.

Q | What’s one thing you learned from your research that you didn’t expect?

When I started I was more focused on the role of protein MCL-1 in cancer cells, however, while working on this research project I got a broader perspective of its involvement not only in cancer cells but also the tumor microenvironment, which I had not envisioned earlier.

Q | If your research succeeds, what could it change for science or society?

My research is primarily focused on finding new and effective treatment strategies for colorectal cancer. Colorectal cancer is a leading cause of cancer-related mortality worldwide and its incidence is recently increasing in young patients aged less than 50 years, so finding treatments which can benefit the therapeutic outcome and survival in these patients is very crucial.

Q | What question are you most excited to answer next?

Nuclear genome has been widely studied in cancer, however recently mitochondrial genome or mitochondrial DNA (mtDNA) is emerging as a potential biomarker in various cancers. My next project would be to see how the modulation in mtDNA can affect colorectal cancer.

Responses have been edited for length and clarity.

Are you a researcher who would like to be featured in the “Postdoc Portraits” series? Send in your application here.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo